Digitalis cardiotoxicity

Area of Science:

• Cardiology
• Clinical Pharmacology

Background:

• Digitalis toxicity has been recognized since 1785, with electrocardiographic documentation beginning in the late 19th century.
• The prevalence of digitalis toxicity increased with the popularization of electrocardiography and the use of digitoxin in high doses.
• Decreased toxicity correlates with better understanding of electrolyte interactions and appropriate digoxin dosing for arrhythmias.

Observation:

• Early electrocardiographs allowed for the recording of digitalis-induced arrhythmias.
• Increased use of digoxin at doses optimized for inotropic effects, rather than arrhythmia management, contributed to a decline in toxicity.
• Serum level determinations and the concept of therapeutic drug levels have helped prevent digitalis toxicity.

Findings:

• This report details arrhythmias highly specific to digitalis toxicity.
• It also discusses arrhythmias that were once common but are now rarely observed.
• Arrhythmias are classified based on their likely electrophysiologic mechanisms.

Implications:

• Understanding these specific arrhythmias aids in diagnosing digitalis toxicity.
• Recognizing less common arrhythmias is crucial for managing complex patient cases.
• This review provides insights into the evolving landscape of digitalis toxicity and its management.